热情的我
发表于 2025-3-23 11:55:14
http://reply.papertrans.cn/59/5875/587438/587438_11.png
量被毁坏
发表于 2025-3-23 15:08:57
http://reply.papertrans.cn/59/5875/587438/587438_12.png
小母马
发表于 2025-3-23 21:58:41
http://reply.papertrans.cn/59/5875/587438/587438_13.png
violate
发表于 2025-3-23 23:07:02
Pre- and Posttransplant Management of Hepatitis C,ansplanted with viremia, and recurrent hepatitis results in higher rates of graft and patient loss compared to other indications for transplantation. The most important factors that predict poor transplant outcome are advanced donor age and treatment of acute rejection. Therapy may be given prior to
增减字母法
发表于 2025-3-24 02:59:28
http://reply.papertrans.cn/59/5875/587438/587438_15.png
解决
发表于 2025-3-24 06:38:11
The Share 15 Rule, on the Model for End-Stage Liver Disease (MELD) score has allowed prioritization to be based on an objective measure of illness. In addition, after institution of the MELD system, policy makers were now able to measure differences among patients, institutions, and geographical areas that are much l
Expressly
发表于 2025-3-24 10:44:37
Hepatocellular Carcinoma,ease in viral hepatitis over the last two decades has led to a dramatic increase in the incidence of HCC in the United States and other Western countries. In fact, the number of patients with HCC listed for transplantation will exceed the total number of available donors in the future. Preoperative
cajole
发表于 2025-3-24 16:24:39
Liver Transplantation and the Hepatopulmonary Syndrome,patients without HPS. The only proven effective therapy for HPS is orthotopic liver transplantation (OLT), which should be considered when severe hypoxemia is present. The natural history of HPS without liver transplantation is dismal. While post-OLT mortality is increased in patients with HPS relat
元音
发表于 2025-3-24 21:02:47
http://reply.papertrans.cn/59/5875/587438/587438_19.png
CHURL
发表于 2025-3-25 00:18:53
Hepatitis B and Liver Transplantation,ge liver disease including hepatocellular carcinoma. Thus, liver transplantation has emerged as an important therapy for selected patients with HBV infection. The authors review the management of HBV before and after liver transplantation, which has become more complex with the advent of several new